In the year since its devastating hack, 23andMe has lost all of its value and most of its governing board — and somehow, ...

The DNA-testing firm said in a Tuesday SEC filing, “there is substantial doubt about the company’s ability to continue.” ...

Me announces 40% workforce reduction and cancellation of therapeutic programs following year of security breaches and ...

In the ever-evolving tech industry, a transformative shift is taking place as women ascend to prominent leadership roles, ...

Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...

In a significant move to stabilize its operations, 23andMe has announced the layoff of 200 employees, representing a ...

The genetic testing firm will also close its therapeutics arm. CEO Anne Wojcicki said the cuts are necessary to “focus on the ...

Embattled genetic testing provider 23andMe said on Tuesday that revenue declined from a year earlier, a day after the company ...

In a prepared statement, 23andMe CEO and co-founder Anne Wojcicki said the company was "taking these difficult but necessary actions” as it focuses on “the long-term success of our core ...

The genetic testing company 23andMe announced it was laying off more than 200 employees, or roughly 40% of its entire ...

We remain deeply grateful to the patients, investigators and study staff for their participation in our clinical trials,” ...

Genetics testing company 23andMe is trimming its headcount by 40%. The company said it is undergoing a restructuring to ...